NPI: 1821184888 · POLSON, MT 59860 · Critical Access Hospital · NPI assigned 10/05/2006
Authorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
| Authorized Official | ANDERSON, DONALD (ASSISTANT SECRETARY OF ENROLLMENTS) |
| Parent Organization | PROVIDENCE HEALTH & SERVICES |
| NPI Enumeration Date | 10/05/2006 |
Other providers sharing the same authorized official: ANDERSON, DONALD
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 39,653 | $71K |
| 2019 | 34,099 | $120K |
| 2020 | 29,080 | $78K |
| 2021 | 38,159 | $100K |
| 2022 | 34,484 | $123K |
| 2023 | 29,386 | $69K |
| 2024 | 22,218 | $92K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 8,078 | 6,737 | $96K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5,386 | 4,031 | $76K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 7,162 | 5,707 | $69K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,410 | 1,285 | $65K |
| 87631 | 2,122 | 2,022 | $30K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 6,673 | 1,903 | $24K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1,746 | 1,664 | $23K |
| 70450 | Computed tomography, head or brain; without contrast material | 1,391 | 1,248 | $21K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1,107 | 1,047 | $18K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2,149 | 1,035 | $13K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,733 | 1,661 | $12K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4,710 | 4,060 | $12K |
| 80053 | Comprehensive metabolic panel | 16,259 | 13,643 | $11K |
| 71046 | Radiologic examination, chest; 2 views | 1,670 | 1,546 | $10K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3,165 | 3,068 | $10K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3,064 | 1,824 | $9K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 554 | 439 | $8K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 16,016 | 13,175 | $8K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,646 | 2,479 | $7K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 978 | 891 | $7K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3,487 | 2,928 | $6K |
| 71045 | Radiologic examination, chest; single view | 2,649 | 2,324 | $6K |
| 80306 | 1,503 | 1,297 | $5K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,205 | 1,026 | $5K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 3,853 | 3,197 | $4K |
| 72125 | Computed tomography, cervical spine; without contrast material | 200 | 190 | $4K |
| 87081 | 2,661 | 2,553 | $4K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 3,786 | 3,076 | $3K |
| 81001 | 4,570 | 4,026 | $3K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2,055 | 1,968 | $3K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2,053 | 1,966 | $3K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 3,388 | 2,930 | $3K |
| 73110 | 507 | 383 | $3K | |
| 81025 | 2,932 | 2,739 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2,443 | 1,981 | $3K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 99 | 95 | $3K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 439 | 384 | $3K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1,439 | 589 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,275 | 1,027 | $2K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 2,071 | 1,575 | $2K |
| 87420 | 527 | 498 | $2K | |
| 83690 | 2,778 | 2,433 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,623 | 1,582 | $2K |
| G0378 | Hospital observation service, per hour | 237 | 99 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | 5,065 | 4,789 | $2K |
| 36415 | Collection of venous blood by venipuncture | 13,885 | 11,866 | $2K |
| 73630 | 666 | 587 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3,319 | 2,904 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 3,592 | 3,279 | $2K |
| 73610 | 726 | 650 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1,373 | 1,324 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,200 | 1,895 | $2K |
| J2704 | Injection, propofol, 10 mg | 1,352 | 1,125 | $2K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 334 | 324 | $2K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 2,573 | 1,381 | $2K |
| J7030 | Infusion, normal saline solution , 1000 cc | 3,293 | 2,677 | $1K |
| 80061 | Lipid panel | 2,607 | 2,549 | $1K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,434 | 2,241 | $1K |
| 85027 | 3,383 | 3,031 | $951.53 | |
| 87077 | 2,041 | 1,885 | $896.62 | |
| 87186 | 1,704 | 1,556 | $874.07 | |
| 82077 | 1,127 | 980 | $812.94 | |
| 81003 | 2,315 | 2,144 | $810.83 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 1,652 | 1,330 | $799.15 |
| 87070 | 736 | 686 | $773.10 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 3,157 | 3,050 | $766.29 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 348 | 285 | $762.79 |
| 86140 | 1,458 | 1,277 | $691.96 | |
| 83605 | 1,051 | 720 | $685.98 | |
| 73030 | 339 | 297 | $666.60 | |
| 73130 | 384 | 321 | $630.27 | |
| 87040 | 629 | 300 | $628.57 | |
| 82728 | 457 | 443 | $616.96 | |
| 84484 | 2,280 | 1,746 | $609.14 | |
| 80305 | 458 | 379 | $605.95 | |
| 81002 | 3,663 | 3,158 | $582.72 | |
| 85652 | 873 | 792 | $480.98 | |
| 96376 | 342 | 276 | $423.59 | |
| 84703 | 699 | 631 | $422.44 | |
| 97161 | 175 | 164 | $422.00 | |
| 84439 | 1,006 | 960 | $387.55 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 637 | 542 | $361.94 |
| J7050 | Infusion, normal saline solution, 250 cc | 2,609 | 1,024 | $352.36 |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 38 | 38 | $316.78 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 736 | 561 | $301.17 |
| 85651 | 747 | 657 | $295.61 | |
| 73562 | 156 | 150 | $277.61 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 414 | 267 | $231.33 |
| 84145 | 129 | 91 | $205.50 | |
| 84702 | 271 | 198 | $200.69 | |
| 85610 | 2,051 | 1,506 | $194.93 | |
| 86900 | 248 | 229 | $183.29 | |
| 97162 | 137 | 129 | $180.00 | |
| 87205 | 648 | 572 | $158.42 | |
| 80143 | 158 | 150 | $150.83 | |
| 80179 | 146 | 137 | $141.65 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 139 | 116 | $138.00 |
| 86901 | 235 | 217 | $137.46 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 26 | 25 | $136.34 |
| 83550 | 86 | 84 | $132.16 | |
| 83880 | 140 | 122 | $127.79 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 924 | 652 | $120.30 |
| 85018 | 230 | 219 | $117.25 | |
| 87210 | 472 | 446 | $104.20 | |
| 83540 | 91 | 89 | $97.76 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 35 | 25 | $74.16 |
| 82962 | 1,340 | 777 | $64.66 | |
| 86803 | 791 | 777 | $62.70 | |
| 73080 | 27 | 24 | $61.24 | |
| 73560 | 44 | 43 | $52.53 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 44 | 39 | $51.25 |
| 87147 | 13 | 13 | $38.94 | |
| J2060 | Injection, lorazepam, 2 mg | 418 | 345 | $30.38 |
| 83735 | 568 | 445 | $29.46 | |
| 82607 | 31 | 27 | $28.50 | |
| 82805 | 42 | 37 | $11.72 | |
| A9270 | Non-covered item or service | 529 | 235 | $2.21 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 305 | 299 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 298 | 297 | $0.00 |
| 86850 | 88 | 84 | $0.00 | |
| 87430 | 13 | 13 | $0.00 | |
| 87340 | 65 | 65 | $0.00 | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 23 | 13 | $0.00 |
| 73502 | 13 | 12 | $0.00 | |
| 84478 | 25 | 25 | $0.00 | |
| 86762 | 13 | 13 | $0.00 | |
| 85379 | 14 | 13 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 65 | 47 | $0.00 |
| 76830 | Ultrasound, transvaginal | 14 | 12 | $0.00 |
| 86592 | 27 | 24 | $0.00 | |
| A9585 | Injection, gadobutrol, 0.1 ml | 14 | 13 | $0.00 |
| 80055 | 14 | 14 | $0.00 | |
| 88342 | 18 | 12 | $0.00 | |
| 82043 | 13 | 12 | $0.00 | |
| J3490 | Unclassified drugs | 18 | 12 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 15 | 12 | $0.00 |
| 87806 | 84 | 81 | $0.00 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 361 | 360 | $0.00 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 124 | 100 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 176 | 151 | $0.00 |
| 82570 | 102 | 90 | $0.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 18 | 17 | $0.00 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 88 | 60 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 149 | 136 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 27 | 24 | $0.00 |
| 87653 | 13 | 12 | $0.00 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 12 | 12 | $0.00 |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 25 | 12 | $0.00 |